Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CGNX Stock Forecast 2026-2027
$40.92
Current Price
$6.86B
Market Cap
Buy 14
Hold 6
Sell 1
Wall St Analyst Ratings
Distance to CGNX Price Targets
+54.0%
To High Target of $63.00
+21.0%
To Median Target of $49.50
-14.5%
To Low Target of $35.00
CGNX Price Momentum
+4.9%
1 Week Change
+13.1%
1 Month Change
+3.0%
1 Year Change
+13.7%
Year-to-Date Change
-17.8%
From 52W High of $49.76
+80.5%
From 52W Low of $22.67
📊 TOP ANALYST CALLS
Did CGNX Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Cognex is one of their latest high-conviction picks.
Latest CGNX Stock Price Targets & Analyst Predictions
Based on our analysis of 25 Wall Street analysts, CGNX has a bullish consensus with a median price target of $49.50 (ranging from $35.00 to $63.00). The overall analyst rating is Strong Buy (8.2/10). Currently trading at $40.92, the median forecast implies a 21.0% upside. This outlook is supported by 14 Buy, 6 Hold, and 1 Sell ratings.
Conversely, the most conservative target is provided by Tomohiko Sano at JP Morgan, suggesting a 14.5% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CGNX Analyst Ratings
14
Buy
6
Hold
1
Sell
CGNX Price Target Range
Low
$35.00
Average
$49.50
High
$63.00
Current: $40.92
Latest CGNX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CGNX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 12, 2026 | Barclays | Guy Hardwick | Overweight | Maintains | $54.00 |
| Dec 18, 2025 | Truist Securities | Jamie Cook | Hold | Maintains | $42.00 |
| Dec 16, 2025 | Goldman Sachs | Joe Ritchie | Buy | Upgrade | $50.00 |
| Dec 3, 2025 | JP Morgan | Tomohiko Sano | Underweight | Downgrade | $35.00 |
| Nov 3, 2025 | DA Davidson | Matthew Summerville | Neutral | Maintains | $38.00 |
| Oct 31, 2025 | Baird | Richard Eastman | Neutral | Maintains | $45.00 |
| Oct 31, 2025 | Barclays | Guy Hardwick | Overweight | Maintains | $56.00 |
| Oct 31, 2025 | Needham | James Ricchiuti | Buy | Maintains | $47.00 |
| Oct 8, 2025 | Truist Securities | Jamie Cook | Hold | Maintains | $45.00 |
| Oct 8, 2025 | Barclays | Guy Hardwick | Overweight | Initiates | $55.00 |
| Sep 16, 2025 | Goldman Sachs | Joe Ritchie | Sell | Maintains | $40.00 |
| Sep 15, 2025 | JP Morgan | Tomohiko Sano | Neutral | Initiates | $45.00 |
| Aug 4, 2025 | DA Davidson | Matthew Summerville | Neutral | Maintains | $35.00 |
| Aug 1, 2025 | Keybanc | Ken Newman | Overweight | Upgrade | $50.00 |
| Aug 1, 2025 | UBS | Damian Karas | Buy | Maintains | $58.00 |
| Aug 1, 2025 | Baird | Neutral | Maintains | $N/A | |
| Jul 31, 2025 | Needham | James Ricchiuti | Buy | Maintains | $45.00 |
| Jul 14, 2025 | Citigroup | Piyush Avasthy | Neutral | Maintains | $37.00 |
| Jun 16, 2025 | DA Davidson | Matthew Summerville | Neutral | Maintains | $32.00 |
| Jun 16, 2025 | Baird | Richard Eastman | Neutral | Maintains | $32.00 |
Cognex Corporation (CGNX) Competitors
The following stocks are similar to Cognex based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Cognex Corporation (CGNX) Financial Data
Cognex Corporation has a market capitalization of $6.86B with a P/E ratio of 62.4x. The company generates $971.71M in trailing twelve-month revenue with a 11.3% profit margin.
Revenue growth is +18.0% quarter-over-quarter, while maintaining an operating margin of +20.9% and return on equity of +7.2%.
Valuation Metrics
Market Cap
$6.86B
Enterprise Value
$6.49B
P/E Ratio
62.4x
PEG Ratio
-1.8x
Price/Sales
7.0x
Growth & Margins
Revenue Growth (YoY)
+18.0%
Gross Margin
+67.6%
Operating Margin
+20.9%
Net Margin
+11.3%
EPS Growth
-40.3%
Financial Health
Cash/Price Ratio
+4.4%
Current Ratio
4.0x
Debt/Equity
5.3x
ROE
+7.2%
ROA
+4.9%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Cognex Corporation (CGNX) Business Model
About Cognex Corporation
What They Do
Develops machine vision systems and software.
Business Model
Cognex Corporation generates revenue by providing machine vision systems, software, and sensors that automate inspection and identification processes across various industries. Its products are crucial for manufacturing and logistics companies to ensure quality control and enhance operational efficiency.
Additional Information
Founded in 1981 and headquartered in Natick, Massachusetts, Cognex serves multiple sectors including automotive, consumer electronics, and pharmaceuticals. The company's commitment to innovation in vision technology solidifies its position as a leader in the industrial automation market.
Company Information
Sector
Technology
Industry
Scientific & Technical Instruments
Employees
2,914
CEO
Mr. Matthew Moschner
Country
United States
IPO Year
1989
Website
www.cognex.comCognex Corporation (CGNX) Latest News & Analysis
Latest News
Quick Summary
Cognex Corporation (NASDAQ: CGNX) will release its Q4 2025 earnings on February 11, 2026, after market close.
Why It Matters
Cognex's upcoming Q4 earnings release may impact stock performance, revealing financial health and growth potential, influencing investor sentiment and decision-making.
Source: PRNewsWire
Market Sentiment:
Neutral
AMG Frontier Small Cap Growth Fund: Q3 Sees Strong Outperformance Across Semiconductor Holdings
1 month ago
Quick Summary
Portfolios underperformed this quarter and year-to-date, primarily due to underweighting biotech in health care and poor stock selection. Position in health care has been significantly reduced.
Why It Matters
Underperformance in portfolios, particularly in health care, signals potential risks. Decreased positions may indicate a shift in strategy, affecting future returns and investor confidence.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Cognex Corporation (CGNX) presented at the Bernstein Insights: 4th Annual Industrials Forum Investor Conference, sharing insights relevant to investors.
Why It Matters
Cognex's presentation at a prominent investor conference signals potential insights into its growth strategy, market position, and financial outlook, influencing investor sentiment and stock performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Cognex Corporation (CGNX) Presents at Goldman Sachs Industrials and Materials Conference 2025 Transcript
1 month ago
Quick Summary
Cognex Corporation (CGNX) presented at the Goldman Sachs Industrials and Materials Conference 2025, indicating engagement with investors and industry insights.
Why It Matters
Cognex's presentation at a major conference signals potential insights into its growth strategies and market position, influencing investor sentiment and stock performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Cognex Corporation's CFO, Dennis Fehr, will present at the Goldman Sachs Industrials and Materials Conference in New York on December 3, 2025, at 12:10 p.m.
Why It Matters
Cognex's CFO presenting at a major investor conference signals potential insights into company performance and strategy, influencing investor sentiment and stock valuation.
Source: PRNewsWire
Market Sentiment:
Neutral
Cognex Corporation (CGNX) Presents at Stephens Annual Investment Conference 2025 Transcript
1 month ago
Quick Summary
Cognex Corporation (CGNX) will participate in the Stephens Annual Investment Conference on November 19, 2025, at 11:00 AM EST, featuring Senior VP Dennis Fehr.
Why It Matters
Cognex's participation in the Stephens Annual Investment Conference provides a platform for key financial insights, potentially influencing investor sentiment and stock performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Frequently Asked Questions About CGNX Stock
What is Cognex Corporation's (CGNX) stock forecast for 2026?
Based on our analysis of 25 Wall Street analysts, Cognex Corporation (CGNX) has a median price target of $49.50. The highest price target is $63.00 and the lowest is $35.00.
Is CGNX stock a good investment in 2026?
According to current analyst ratings, CGNX has 14 Buy ratings, 6 Hold ratings, and 1 Sell ratings. The stock is currently trading at $40.92. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CGNX stock?
Wall Street analysts predict CGNX stock could reach $49.50 in the next 12 months. This represents a 21.0% increase from the current price of $40.92. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Cognex Corporation's business model?
Cognex Corporation generates revenue by providing machine vision systems, software, and sensors that automate inspection and identification processes across various industries. Its products are crucial for manufacturing and logistics companies to ensure quality control and enhance operational efficiency.
What is the highest forecasted price for CGNX Cognex Corporation?
The highest price target for CGNX is $63.00 from at , which represents a 54.0% increase from the current price of $40.92.
What is the lowest forecasted price for CGNX Cognex Corporation?
The lowest price target for CGNX is $35.00 from Tomohiko Sano at JP Morgan, which represents a -14.5% decrease from the current price of $40.92.
What is the overall CGNX consensus from analysts for Cognex Corporation?
The overall analyst consensus for CGNX is bullish. Out of 25 Wall Street analysts, 14 rate it as Buy, 6 as Hold, and 1 as Sell, with a median price target of $49.50.
How accurate are CGNX stock price projections?
Stock price projections, including those for Cognex Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: January 18, 2026 12:50 PM UTC